ID   ADCYA_HUMAN             Reviewed;        1610 AA.
AC   Q96PN6; B4DZF0; F5GWS5; O95558; Q5R329; Q5R330; Q8WXV4; Q9NNX0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=Adenylate cyclase type 10;
DE            EC=4.6.1.1 {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695};
DE   AltName: Full=AH-related protein;
DE   AltName: Full=Adenylate cyclase homolog;
DE   AltName: Full=Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};
DE            Short=hsAC;
DE            Short=sAC {ECO:0000303|PubMed:12609998, ECO:0000303|PubMed:25040695};
DE   AltName: Full=Testicular soluble adenylyl cyclase;
GN   Name=ADCY10; Synonyms=SAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-697.
RX   PubMed=11423534; DOI=10.1074/jbc.M011698200;
RA   Jaiswal B.S., Conti M.;
RT   "Identification and functional analysis of splice variants of the germ
RT   cell soluble adenylyl cyclase.";
RL   J. Biol. Chem. 276:31698-31708(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   INVOLVEMENT IN HCA2, AND VARIANT VAL-697.
RC   TISSUE=Intestine;
RX   PubMed=11932268; DOI=10.1210/jcem.87.4.8300;
RA   Reed B.Y., Gitomer W.L., Heller H.J., Hsu M.C., Lemke M., Padalino P.,
RA   Pak C.Y.C.;
RT   "Identification and characterization of a gene with base substitutions
RT   associated with the absorptive hypercalciuria phenotype and low spinal
RT   bone density.";
RL   J. Clin. Endocrinol. Metab. 87:1476-1485(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), COFACTOR, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, AND VARIANT
RP   VAL-697.
RX   PubMed=12609998; DOI=10.1074/jbc.M212475200;
RA   Litvin T.N., Kamenetsky M., Zarifyan A., Buck J., Levin L.R.;
RT   "Kinetic properties of 'soluble' adenylyl cyclase. Synergism between
RT   calcium and bicarbonate.";
RL   J. Biol. Chem. 278:15922-15926(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Khole V.V., Westbrook V.A., Mandal A., Herr J.C., Visconti P.E.;
RT   "Cloning of a human testicular soluble adenylyl cyclase.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Rhodes S.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12475901; DOI=10.1096/fj.02-0598fje;
RA   Zippin J.H., Chen Y., Nahirney P., Kamenetsky M., Wuttke M.S.,
RA   Fischman D.A., Levin L.R., Buck J.;
RT   "Compartmentalization of bicarbonate-sensitive adenylyl cyclase in
RT   distinct signaling microdomains.";
RL   FASEB J. 17:82-84(2003).
RN   [11]
RP   CATALYTIC ACTIVITY, COFACTOR, TISSUE SPECIFICITY, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15659711; DOI=10.1152/ajpcell.00584.2004;
RA   Geng W., Wang Z., Zhang J., Reed B.Y., Pak C.Y.C., Moe O.W.;
RT   "Cloning and characterization of the human soluble adenylyl cyclase.";
RL   Am. J. Physiol. 288:C1305-C1316(2005).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17591988; DOI=10.1085/jgp.200709784;
RA   Schmid A., Sutto Z., Nlend M.-C., Horvath G., Schmid N., Buck J.,
RA   Levin L.R., Conner G.E., Fregien N., Salathe M.;
RT   "Soluble adenylyl cyclase is localized to cilia and contributes to
RT   ciliary beat frequency regulation via production of cAMP.";
RL   J. Gen. Physiol. 130:99-109(2007).
RN   [13] {ECO:0000244|PDB:4OYA, ECO:0000244|PDB:4OYB, ECO:0000244|PDB:4OYI}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-469 IN COMPLEX WITH
RP   HYDROGENCARBONATE; CALCIUM AND ATP ANALOG, CATALYTIC ACTIVITY,
RP   FUNCTION, COFACTOR, AND DOMAIN.
RX   PubMed=24616449; DOI=10.1002/cmdc.201300480;
RA   Saalau-Bethell S.M., Berdini V., Cleasby A., Congreve M., Coyle J.E.,
RA   Lock V., Murray C.W., O'Brien M.A., Rich S.J., Sambrook T.,
RA   Vinkovic M., Yon J.R., Jhoti H.;
RT   "Crystal structure of human soluble adenylate cyclase reveals a
RT   distinct, highly flexible allosteric bicarbonate binding pocket.";
RL   ChemMedChem 9:823-832(2014).
RN   [14] {ECO:0000244|PDB:4UST, ECO:0000244|PDB:4USU, ECO:0000244|PDB:4USV}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-469 IN COMPLEXES WITH
RP   MAGNESIUM; CALCIUM; ATP AND ATP ANALOGS, FUNCTION, COFACTOR, CATALYTIC
RP   ACTIVITY, ENZYME REGULATION, AND DOMAIN.
RX   PubMed=25040695; DOI=10.1111/febs.12913;
RA   Kleinboelting S., van den Heuvel J., Steegborn C.;
RT   "Structural analysis of human soluble adenylyl cyclase and crystal
RT   structures of its nucleotide complexes-implications for cyclase
RT   catalysis and evolution.";
RL   FEBS J. 281:4151-4164(2014).
RN   [15] {ECO:0000244|PDB:4CLF, ECO:0000244|PDB:4CLK, ECO:0000244|PDB:4CLL}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-469 IN COMPLEX WITH
RP   CALCIUM; HYDROGENCARBONATE AND ATP ANALOGS, CATALYTIC ACTIVITY,
RP   COFACTOR, FUNCTION, ENZYME REGULATION, MUTAGENESIS OF LYS-95 AND
RP   ARG-176, AND DOMAIN.
RX   PubMed=24567411; DOI=10.1073/pnas.1322778111;
RA   Kleinboelting S., Diaz A., Moniot S., van den Heuvel J., Weyand M.,
RA   Levin L.R., Buck J., Steegborn C.;
RT   "Crystal structures of human soluble adenylyl cyclase reveal
RT   mechanisms of catalysis and of its activation through bicarbonate.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:3727-3732(2014).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP
CC       (PubMed:12609998, PubMed:15659711, PubMed:24616449,
CC       PubMed:25040695, PubMed:24567411). May function as sensor that
CC       mediates responses to changes in cellular bicarbonate and CO(2)
CC       levels (PubMed:15659711, PubMed:17591988). Has a critical role in
CC       mammalian spermatogenesis by producing the cAMP which regulates
CC       cAMP-responsive nuclear factors indispensable for sperm maturation
CC       in the epididymis. Induces capacitation, the maturational process
CC       that sperm undergo prior to fertilization (By similarity).
CC       Involved in ciliary beat regulation (PubMed:17591988).
CC       {ECO:0000250|UniProtKB:Q8C0T9, ECO:0000269|PubMed:15659711,
CC       ECO:0000269|PubMed:17591988, ECO:0000269|PubMed:24567411,
CC       ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.
CC   -!- CATALYTIC ACTIVITY: ATP = 3',5'-cyclic AMP + diphosphate.
CC       {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711,
CC       ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449,
CC       ECO:0000269|PubMed:25040695}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12609998,
CC         ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411,
CC         ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24616449};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12609998,
CC         ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24616449};
CC       Note=Binds 2 magnesium ions per subunit (PubMed:25040695). Is also
CC       active with manganese (in vitro) (PubMed:12609998,
CC       PubMed:15659711, PubMed:24616449). {ECO:0000269|PubMed:12609998,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24616449,
CC       ECO:0000305|PubMed:25040695};
CC   -!- ENZYME REGULATION: Activated by manganese or magnesium ions
CC       (PubMed:12609998, PubMed:24616449). In the presence of magnesium
CC       ions, the enzyme is activated by bicarbonate (PubMed:12609998,
CC       PubMed:15659711, PubMed:24567411). In the presence of manganese
CC       ions, the enzyme is inhibited by bicarbonate (PubMed:15659711). In
CC       the absence of magnesium and bicarbonate, the enzyme is weakly
CC       activated by calcium (PubMed:15659711). Calcium mildly increases
CC       the enzyme activity, also in the presence of magnesium ions
CC       (PubMed:15659711, PubMed:25040695). {ECO:0000269|PubMed:12609998,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411,
CC       ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.8 mM for ATP-Mn(2+) {ECO:0000269|PubMed:12609998};
CC         KM=2.41 mM for Mg(2+) {ECO:0000269|PubMed:12609998};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15659711};
CC       Peripheral membrane protein {ECO:0000269|PubMed:15659711};
CC       Cytoplasmic side {ECO:0000269|PubMed:15659711}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:12475901,
CC       ECO:0000269|PubMed:15659711}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}.
CC       Nucleus {ECO:0000269|PubMed:12475901,
CC       ECO:0000269|PubMed:15659711}. Cell projection, cilium
CC       {ECO:0000269|PubMed:17591988}. Cytoplasm
CC       {ECO:0000269|PubMed:12475901}. Mitochondrion
CC       {ECO:0000269|PubMed:12475901}. Note=Distributed to subcellular
CC       compartments containing cAMP targets. Found as a plasma membrane-
CC       associated protein, protein concentrated in the perinuclear region
CC       and protein colocalized with actin or tubulin.
CC       {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96PN6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96PN6-2; Sequence=VSP_030867;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96PN6-3; Sequence=VSP_030866, VSP_030868, VSP_030869,
CC                                  VSP_030870;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q96PN6-4; Sequence=VSP_046329;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in airway epithelial cells and testis
CC       (at protein level) (PubMed:17591988). Weakly expressed in multiple
CC       tissues. Expressed in brain, heart, kidney, liver, lung, pancreas,
CC       peripheral blood leukocytes, placenta, skeletal muscle, stomach,
CC       thymus, airway epithelial cells, duodenum, jejunum and ileum. Very
CC       low level of expression in bone. {ECO:0000269|PubMed:11932268,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:17591988}.
CC   -!- DOMAIN: The N-terminal guanylate cyclase domains are required for
CC       enzyme activity. Fragments or isoforms containing the first 470
CC       amino acid residues are fully active.
CC       {ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449,
CC       ECO:0000269|PubMed:25040695}.
CC   -!- PTM: Cleavage may occur to generate the active 48 kDa form.
CC       {ECO:0000305}.
CC   -!- DISEASE: Hypercalciuria absorptive 2 (HCA2) [MIM:143870]: A common
CC       type of hypercalciuria, a condition characterized by excessive
CC       urinary calcium excretion. Absorptive hypercalciuria is due to
CC       gastrointestinal hyperabsorption of calcium and is a frequent
CC       cause of calcium oxalate nephrolithiasis.
CC       {ECO:0000269|PubMed:11932268}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF271058; AAF74296.1; -; mRNA.
DR   EMBL; AF331033; AAL57036.1; -; mRNA.
DR   EMBL; AF176813; AAF65931.1; -; mRNA.
DR   EMBL; AF299350; AAK96045.1; -; mRNA.
DR   EMBL; AL035122; CAA22684.1; -; mRNA.
DR   EMBL; AK302884; BAG64062.1; -; mRNA.
DR   EMBL; Z97876; CAI20073.1; -; Genomic_DNA.
DR   EMBL; Z99943; CAI20073.1; JOINED; Genomic_DNA.
DR   EMBL; Z97876; CAI20074.1; -; Genomic_DNA.
DR   EMBL; Z99943; CAI20074.1; JOINED; Genomic_DNA.
DR   EMBL; Z99943; CAI20146.1; -; Genomic_DNA.
DR   EMBL; Z97876; CAI20146.1; JOINED; Genomic_DNA.
DR   EMBL; Z99943; CAI20147.1; -; Genomic_DNA.
DR   EMBL; Z97876; CAI20147.1; JOINED; Genomic_DNA.
DR   EMBL; CH471067; EAW90804.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90807.1; -; Genomic_DNA.
DR   EMBL; BC117366; AAI17367.1; -; mRNA.
DR   EMBL; BC117372; AAI17373.1; -; mRNA.
DR   CCDS; CCDS1265.1; -. [Q96PN6-1]
DR   CCDS; CCDS53426.1; -. [Q96PN6-4]
DR   CCDS; CCDS72977.1; -. [Q96PN6-2]
DR   RefSeq; NP_001161221.1; NM_001167749.2. [Q96PN6-4]
DR   RefSeq; NP_001284701.1; NM_001297772.1. [Q96PN6-2]
DR   RefSeq; NP_060887.2; NM_018417.5. [Q96PN6-1]
DR   RefSeq; XP_011508062.1; XM_011509760.2. [Q96PN6-1]
DR   UniGene; Hs.320892; -.
DR   PDB; 4CLF; X-ray; 1.70 A; A=1-469.
DR   PDB; 4CLK; X-ray; 2.20 A; A=1-469.
DR   PDB; 4CLL; X-ray; 1.70 A; A=1-469.
DR   PDB; 4CLP; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CLS; X-ray; 1.85 A; A=1-469.
DR   PDB; 4CLT; X-ray; 1.95 A; A=1-469.
DR   PDB; 4CLU; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CLW; X-ray; 2.15 A; A=1-469.
DR   PDB; 4CLY; X-ray; 2.05 A; A=1-469.
DR   PDB; 4CLZ; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CM0; X-ray; 3.20 A; A=1-469.
DR   PDB; 4CM2; X-ray; 1.80 A; A=1-469.
DR   PDB; 4OYA; X-ray; 2.03 A; A=1-469.
DR   PDB; 4OYB; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYI; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYM; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYO; X-ray; 1.75 A; A=1-469.
DR   PDB; 4OYP; X-ray; 2.28 A; A=1-469.
DR   PDB; 4OYW; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYX; X-ray; 1.89 A; A=1-469.
DR   PDB; 4OYZ; X-ray; 1.74 A; A=1-469.
DR   PDB; 4OZ2; X-ray; 2.10 A; A=1-469.
DR   PDB; 4OZ3; X-ray; 1.70 A; A=1-469.
DR   PDB; 4UST; X-ray; 1.90 A; A=1-469.
DR   PDB; 4USU; X-ray; 1.95 A; A=1-469.
DR   PDB; 4USV; X-ray; 2.00 A; A=1-469.
DR   PDB; 4USW; X-ray; 2.05 A; A=1-469.
DR   PDB; 5D0R; X-ray; 2.24 A; A=1-469.
DR   PDB; 5IV3; X-ray; 1.86 A; A=1-469.
DR   PDB; 5IV4; X-ray; 1.79 A; A=1-469.
DR   PDBsum; 4CLF; -.
DR   PDBsum; 4CLK; -.
DR   PDBsum; 4CLL; -.
DR   PDBsum; 4CLP; -.
DR   PDBsum; 4CLS; -.
DR   PDBsum; 4CLT; -.
DR   PDBsum; 4CLU; -.
DR   PDBsum; 4CLW; -.
DR   PDBsum; 4CLY; -.
DR   PDBsum; 4CLZ; -.
DR   PDBsum; 4CM0; -.
DR   PDBsum; 4CM2; -.
DR   PDBsum; 4OYA; -.
DR   PDBsum; 4OYB; -.
DR   PDBsum; 4OYI; -.
DR   PDBsum; 4OYM; -.
DR   PDBsum; 4OYO; -.
DR   PDBsum; 4OYP; -.
DR   PDBsum; 4OYW; -.
DR   PDBsum; 4OYX; -.
DR   PDBsum; 4OYZ; -.
DR   PDBsum; 4OZ2; -.
DR   PDBsum; 4OZ3; -.
DR   PDBsum; 4UST; -.
DR   PDBsum; 4USU; -.
DR   PDBsum; 4USV; -.
DR   PDBsum; 4USW; -.
DR   PDBsum; 5D0R; -.
DR   PDBsum; 5IV3; -.
DR   PDBsum; 5IV4; -.
DR   ProteinModelPortal; Q96PN6; -.
DR   SMR; Q96PN6; -.
DR   STRING; 9606.ENSP00000356825; -.
DR   BindingDB; Q96PN6; -.
DR   ChEMBL; CHEMBL5854; -.
DR   iPTMnet; Q96PN6; -.
DR   PhosphoSitePlus; Q96PN6; -.
DR   SwissPalm; Q96PN6; -.
DR   BioMuta; ADCY10; -.
DR   DMDM; 308153637; -.
DR   EPD; Q96PN6; -.
DR   PaxDb; Q96PN6; -.
DR   PeptideAtlas; Q96PN6; -.
DR   PRIDE; Q96PN6; -.
DR   Ensembl; ENST00000367848; ENSP00000356822; ENSG00000143199. [Q96PN6-2]
DR   Ensembl; ENST00000367851; ENSP00000356825; ENSG00000143199. [Q96PN6-1]
DR   Ensembl; ENST00000545172; ENSP00000441992; ENSG00000143199. [Q96PN6-4]
DR   GeneID; 55811; -.
DR   KEGG; hsa:55811; -.
DR   UCSC; uc001ger.4; human. [Q96PN6-1]
DR   CTD; 55811; -.
DR   DisGeNET; 55811; -.
DR   GeneCards; ADCY10; -.
DR   H-InvDB; HIX0200024; -.
DR   HGNC; HGNC:21285; ADCY10.
DR   HPA; HPA015243; -.
DR   HPA; HPA017749; -.
DR   MalaCards; ADCY10; -.
DR   MIM; 143870; phenotype.
DR   MIM; 605205; gene.
DR   neXtProt; NX_Q96PN6; -.
DR   OpenTargets; ENSG00000143199; -.
DR   Orphanet; 2197; Idiopathic hypercalciuria.
DR   PharmGKB; PA162375618; -.
DR   eggNOG; ENOG410IEPA; Eukaryota.
DR   eggNOG; ENOG410ZFMC; LUCA.
DR   GeneTree; ENSGT00390000001322; -.
DR   HOGENOM; HOG000060149; -.
DR   HOVERGEN; HBG103835; -.
DR   InParanoid; Q96PN6; -.
DR   KO; K11265; -.
DR   OMA; PLESCQC; -.
DR   OrthoDB; EOG091G00BV; -.
DR   PhylomeDB; Q96PN6; -.
DR   TreeFam; TF329284; -.
DR   BRENDA; 4.6.1.1; 2681.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SIGNOR; Q96PN6; -.
DR   GeneWiki; ADCY10; -.
DR   GenomeRNAi; 55811; -.
DR   PRO; PR:Q96PN6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143199; -.
DR   CleanEx; HS_ADCY10; -.
DR   ExpressionAtlas; Q96PN6; baseline and differential.
DR   Genevisible; Q96PN6; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0045178; C:basal part of cell; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; NAS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004016; F:adenylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0071890; F:bicarbonate binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0071241; P:cellular response to inorganic substance; IDA:UniProtKB.
DR   GO; GO:0003351; P:epithelial cilium movement; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 2.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR016577; Adenylate_cylcase_typ10.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF011131; Soluble_adenylyl_cyclase; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; cAMP biosynthesis;
KW   Cell membrane; Cell projection; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Lyase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Mitochondrion; Nucleotide-binding; Nucleus; Polymorphism;
KW   Reference proteome; Repeat.
FT   CHAIN         1   1610       Adenylate cyclase type 10.
FT                                /FTId=PRO_0000317101.
FT   DOMAIN       42    179       Guanylate cyclase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   DOMAIN      293    418       Guanylate cyclase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   NP_BIND      47     52       ATP. {ECO:0000244|PDB:4USW,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   NP_BIND     412    416       ATP. {ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449,
FT                                ECO:0000305|PubMed:25040695}.
FT   METAL        47     47       Magnesium 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   METAL        47     47       Magnesium 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   METAL        48     48       Magnesium 2; via carbonyl oxygen.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL        99     99       Magnesium 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   METAL        99     99       Magnesium 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   BINDING      95     95       Bicarbonate. {ECO:0000244|PDB:4CLL,
FT                                ECO:0000244|PDB:4OYZ,
FT                                ECO:0000269|PubMed:24567411,
FT                                ECO:0000269|PubMed:24616449}.
FT   BINDING      99     99       ATP. {ECO:0000244|PDB:4USW,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   BINDING     144    144       ATP. {ECO:0000244|PDB:4USW,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   BINDING     167    167       Bicarbonate; via amide nitrogen and
FT                                carbonyl oxygen. {ECO:0000244|PDB:4CLL,
FT                                ECO:0000244|PDB:4OYZ,
FT                                ECO:0000269|PubMed:24567411,
FT                                ECO:0000269|PubMed:24616449}.
FT   BINDING     176    176       Bicarbonate. {ECO:0000244|PDB:4CLL,
FT                                ECO:0000244|PDB:4OYZ,
FT                                ECO:0000269|PubMed:24567411,
FT                                ECO:0000269|PubMed:24616449}.
FT   BINDING     337    337       Bicarbonate; via amide nitrogen.
FT                                {ECO:0000244|PDB:4CLL,
FT                                ECO:0000244|PDB:4OYZ,
FT                                ECO:0000269|PubMed:24567411,
FT                                ECO:0000269|PubMed:24616449}.
FT   BINDING     406    406       ATP; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:4USW,
FT                                ECO:0000269|PubMed:25040695,
FT                                ECO:0000305|PubMed:24567411,
FT                                ECO:0000305|PubMed:24616449}.
FT   VAR_SEQ       1   1099       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030866.
FT   VAR_SEQ       1    153       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046329.
FT   VAR_SEQ       1     97       MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDG
FT                                VLMFVDISGFTAMTEKFSSAMYMDRGAEQLVEILNYHISAI
FT                                VEKVLIFGGDILKFA -> MSLSE (in isoform 2).
FT                                {ECO:0000303|PubMed:11932268}.
FT                                /FTId=VSP_030867.
FT   VAR_SEQ    1100   1103       DNYM -> MLFK (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030868.
FT   VAR_SEQ    1430   1471       YARLQEWDNFYKFSNRAKNLLPRRTMTLTYYDGISRYMEGQ
FT                                V -> ECEAGVGRRLHTSRDPGMPDFRNGTTFTNFPIELKI
FT                                FCQEEP (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030869.
FT   VAR_SEQ    1472   1610       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030870.
FT   VARIANT     234    234       T -> M (in dbSNP:rs16859886).
FT                                /FTId=VAR_038476.
FT   VARIANT     697    697       I -> V (in dbSNP:rs2071921).
FT                                {ECO:0000269|PubMed:11423534,
FT                                ECO:0000269|PubMed:11932268,
FT                                ECO:0000269|PubMed:12609998}.
FT                                /FTId=VAR_038477.
FT   MUTAGEN      95     95       K->A: Nearly abolishes bicarbonate-
FT                                mediated increase of enzyme activity.
FT                                Abolishes bicarbonate-mediated increase
FT                                of enzyme activity; when associated with
FT                                A-176. {ECO:0000269|PubMed:24567411}.
FT   MUTAGEN     176    176       R->A: Reduces bicarbonate-mediated
FT                                increase of enzyme activity. Abolishes
FT                                bicarbonate-mediated increase of enzyme
FT                                activity; when associated with A-95.
FT                                {ECO:0000269|PubMed:24567411}.
FT   CONFLICT    942    942       L -> P (in Ref. 6; BAG64062).
FT                                {ECO:0000305}.
FT   CONFLICT   1359   1359       L -> P (in Ref. 4; AAK96045).
FT                                {ECO:0000305}.
FT   HELIX        12     17       {ECO:0000244|PDB:4CLF}.
FT   HELIX        22     25       {ECO:0000244|PDB:4CLF}.
FT   STRAND       33     47       {ECO:0000244|PDB:4CLF}.
FT   HELIX        49     52       {ECO:0000244|PDB:4CLF}.
FT   HELIX        55     59       {ECO:0000244|PDB:4CLF}.
FT   HELIX        61     63       {ECO:0000244|PDB:4CLF}.
FT   HELIX        67     88       {ECO:0000244|PDB:4CLF}.
FT   STRAND       92     96       {ECO:0000244|PDB:4CLF}.
FT   STRAND       98    106       {ECO:0000244|PDB:4CLF}.
FT   HELIX       109    111       {ECO:0000244|PDB:4CLF}.
FT   HELIX       112    129       {ECO:0000244|PDB:4CLF}.
FT   TURN        130    132       {ECO:0000244|PDB:4OYB}.
FT   STRAND      135    138       {ECO:0000244|PDB:4OYB}.
FT   STRAND      144    158       {ECO:0000244|PDB:4CLF}.
FT   STRAND      163    169       {ECO:0000244|PDB:4CLF}.
FT   HELIX       170    181       {ECO:0000244|PDB:4CLF}.
FT   STRAND      187    189       {ECO:0000244|PDB:4CLF}.
FT   HELIX       191    196       {ECO:0000244|PDB:4CLF}.
FT   HELIX       199    201       {ECO:0000244|PDB:4CLF}.
FT   STRAND      202    207       {ECO:0000244|PDB:4CLF}.
FT   STRAND      210    218       {ECO:0000244|PDB:4CLF}.
FT   HELIX       226    234       {ECO:0000244|PDB:4CLF}.
FT   HELIX       243    245       {ECO:0000244|PDB:4CLF}.
FT   HELIX       251    254       {ECO:0000244|PDB:4CLF}.
FT   HELIX       259    266       {ECO:0000244|PDB:4CLF}.
FT   HELIX       271    277       {ECO:0000244|PDB:4CLF}.
FT   TURN        283    286       {ECO:0000244|PDB:4CLF}.
FT   STRAND      288    302       {ECO:0000244|PDB:4CLF}.
FT   HELIX       307    327       {ECO:0000244|PDB:4CLF}.
FT   STRAND      331    337       {ECO:0000244|PDB:4CLF}.
FT   STRAND      339    349       {ECO:0000244|PDB:4CLF}.
FT   TURN        351    353       {ECO:0000244|PDB:4OYW}.
FT   HELIX       358    374       {ECO:0000244|PDB:4CLF}.
FT   STRAND      379    398       {ECO:0000244|PDB:4CLF}.
FT   STRAND      401    408       {ECO:0000244|PDB:4CLF}.
FT   HELIX       409    420       {ECO:0000244|PDB:4CLF}.
FT   STRAND      424    427       {ECO:0000244|PDB:4CLF}.
FT   HELIX       429    435       {ECO:0000244|PDB:4CLF}.
FT   HELIX       439    441       {ECO:0000244|PDB:4CLF}.
FT   STRAND      442    444       {ECO:0000244|PDB:4CLF}.
FT   STRAND      460    462       {ECO:0000244|PDB:4CLF}.
FT   STRAND      465    467       {ECO:0000244|PDB:4OYZ}.
SQ   SEQUENCE   1610 AA;  187149 MW;  E0E205747120EFE0 CRC64;
     MNTPKEEFQD WPIVRIAAHL PDLIVYGHFS PERPFMDYFD GVLMFVDISG FTAMTEKFSS
     AMYMDRGAEQ LVEILNYHIS AIVEKVLIFG GDILKFAGDA LLALWRVERK QLKNIITVVI
     KCSLEIHGLF ETQEWEEGLD IRVKIGLAAG HISMLVFGDE THSHFLVIGQ AVDDVRLAQN
     MAQMNDVILS PNCWQLCDRS MIEIESVPDQ RAVKVNFLKP PPNFNFDEFF TKCTTFMHYY
     PSGEHKNLLR LACTLKPDPE LEMSLQKYVM ESILKQIDNK QLQGYLSELR PVTIVFVNLM
     FEDQDKAEEI GPAIQDAYMH ITSVLKIFQG QINKVFMFDK GCSFLCVFGF PGEKVPDELT
     HALECAMDIF DFCSQVHKIQ TVSIGVASGI VFCGIVGHTV RHEYTVIGQK VNLAARMMMY
     YPGIVTCDSV TYNGSNLPAY FFKELPKKVM KGVADSGPLY QYWGRTEKVM FGMACLICNR
     KEDYPLLGRN KEINYFMYTM KKFLISNSSQ VLMYEGLPGY GKSQILMKIE YLAQGKNHRI
     IAISLNKISF HQTFYTIQMF MANVLGLDTC KHYKERQTNL RNKVMTLLDE KFYCLLNDIF
     HVQFPISREI SRMSTLKKQK QLEILFMKIL KLIVKEERII FIIDEAQFVD STSWRFMEKL
     IRTLPIFIIM SLCPFVNIPC AAARAVIKNR NTTYIVIGAV QPNDISNKIC LDLNVSCISK
     ELDSYLGEGS CGIPFYCEEL LKNLEHHEVL VFQQTESEEK TNRTWNNLFK YSIKLTEKLN
     MVTLHSDKES EEVCHLTSGV RLKNLSPPTS LKEISLIQLD SMRLSHQMLV RCAAIIGLTF
     TTELLFEILP CWNMKMMIKT LATLVESNIF YCFRNGKELQ KALKQNDPSF EVHYRSLSLK
     PSEGMDHGEE EQLRELENEV IECHRIRFCN PMMQKTAYEL WLKDQRKAMH LKCARFLEED
     AHRCDHCRGR DFIPYHHFTV NIRLNALDMD AIKKMAMSHG FKTEEKLILS NSEIPETSAF
     FPENRSPEEI REKILNFFDH VLTKMKTSDE DIIPLESCQC EEILEIVILP LAHHFLALGE
     NDKALYYFLE IASAYLIFCD NYMAYMYLNE GQKLLKTLKK DKSWSQTFES ATFYSLKGEV
     CFNMGQIVLA KKMLRKALKL LNRIFPYNLI SLFLHIHVEK NRHFHYVNRQ AQESPPPGKK
     RLAQLYRQTV CLSLLWRIYS YSYLFHCKYY AHLAVMMQMN TALETQNCFQ IIKAYLDYSL
     YHHLAGYKGV WFKYEVMAME HIFNLPLKGE GIEIVAYVAE TLVFNKLIMG HLDLAIELGS
     RALQMWALLQ NPNRHYQSLC RLSRCLLLNS RYPQLIQVLG RLWELSVTQE HIFSKAFFYF
     VCLDILLYSG FVYRTFEECL EFIHQYENNR ILKFHSGLLL GLYSSVAIWY ARLQEWDNFY
     KFSNRAKNLL PRRTMTLTYY DGISRYMEGQ VLHLQKQIKE QSENAQASGE ELLKNLENLV
     AQNTTGPVFC PRLYHLMAYV CILMGDGQKC GLFLNTALRL SETQGNILEK CWLNMNKESW
     YSTSELKEDQ WLQTILSLPS WEKIVAGRVN IQDLQKNKFL MRANTVDNHF
//
